BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1625204)

  • 1. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
    Preston KL; Sullivan JT; Strain EC; Bigelow GE
    J Pharmacol Exp Ther; 1992 Jul; 262(1):279-91. PubMed ID: 1625204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
    Preston KL; Sullivan JT; Berger P; Bigelow GE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):296-307. PubMed ID: 8229755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
    Foltin RW; Fischman MW
    J Pharmacol Exp Ther; 1992 May; 261(2):623-32. PubMed ID: 1578376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone.
    Foltin RW; Christiansen I; Levin FR; Fischman MW
    J Pharmacol Exp Ther; 1995 Oct; 275(1):38-47. PubMed ID: 7562574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
    Preston KL; Sullivan JT; Strain EC; Bigelow GE
    NIDA Res Monogr; 1990; 105():507. PubMed ID: 1876101
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users.
    Sullivan JT; Becker PM; Preston KL; Wise RA; Wigely FM; Testa MP; Jasinski DR
    Am J Med; 1997 Mar; 102(3):232-8. PubMed ID: 9217590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine alters the effects of intravenous cocaine in humans.
    Walsh SL; Preston KL; Sullivan JT; Fromme R; Bigelow GE
    J Clin Psychopharmacol; 1994 Dec; 14(6):396-407. PubMed ID: 7884020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
    Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
    J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.
    Henningfield JE; Miyasato K; Jasinski DR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):1-12. PubMed ID: 4009494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects.
    Rush CR; Sullivan JT; Griffiths RR
    J Pharmacol Exp Ther; 1995 Apr; 273(1):351-8. PubMed ID: 7714788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benztropine pretreatment does not affect responses to acute cocaine administration in human volunteers.
    Penetar DM; Looby AR; Su Z; Lundahl LH; Erös-Sarnyai M; McNeil JF; Lukas SE
    Hum Psychopharmacol; 2006 Dec; 21(8):549-59. PubMed ID: 17080501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1987 Mar; 240(3):900-10. PubMed ID: 3559982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
    Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results.
    McCance-Katz EF; Kosten TR; Jatlow P
    Biol Psychiatry; 1998 Apr; 43(7):540-3. PubMed ID: 9547934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism.
    Farré M; de la Torre R; González ML; Terán MT; Roset PN; Menoyo E; Camí J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):164-76. PubMed ID: 9336321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats.
    Knuepfer MM; Gan Q
    J Pharmacol Exp Ther; 1997 Nov; 283(2):592-603. PubMed ID: 9353374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.